Dakota Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
10,607
+265
+3% +$45.5K 0.04% 309
2026
Q1
$1.75M Buy
10,342
+6,930
+203% +$1.19M 0.04% 306
2025
Q4
$576K Buy
3,412
+239
+8% +$38.8K 0.01% 522
2025
Q3
$458K Sell
3,173
-1,526
-32% -$208K 0.01% 496
2025
Q2
$594K Sell
4,699
-10,644
-69% -$1.31M 0.01% 487
2025
Q1
$1.96M Sell
15,343
-887
-5% -$120K 0.05% 261
2024
Q4
$2.15M Sell
16,230
-1,199
-7% -$169K 0.05% 252
2024
Q3
$2.54M Buy
17,429
+66
+0.4% +$9.55K 0.06% 237
2024
Q2
$2.38M Sell
17,363
-305
-2% -$40.7K 0.06% 241
2024
Q1
$2.42M Buy
17,668
+5,355
+43% +$731K 0.06% 240
2023
Q4
$1.67M Sell
12,313
-34
-0.3% -$4.15K 0.07% 240
2023
Q3
$1.51M Buy
+12,347
New +$1.57M 0.07% 234
2019
Q2
Sell
-5,139
Closed -$575K 296
2019
Q1
$575K Sell
5,139
-1,468
-22% -$161K 0.11% 163
2018
Q4
$806K Hold
6,607
0.18% 103
2018
Q3
$806K Sell
6,607
-4,898
-43% -$577K 0.18% 105
2018
Q2
$1.26M Buy
+11,505
New +$1.23M 0.35% 69

Other funds holding IBB

Dakota Wealth Management's IBB Position: Q2 2026 in Review

Dakota Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, buying an estimated $45.5K and bringing the position to 10,607 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #309.

Dakota Wealth Management first reported a position in IBB in Q2 2018 and has held it in 16 quarters since. The position peaked at $2.54M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Dakota Wealth Management held 10,607 shares of iShares Biotechnology ETF worth $2.02M as of Q2 2026.
  • Dakota Wealth Management bought 265 iShares Biotechnology ETF shares in Q2 2026, an estimated $45.5K.
  • iShares Biotechnology ETF made up 0.04% of Dakota Wealth Management's portfolio in Q2 2026, its #309 holding.
  • Dakota Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 16 quarters since.
  • Dakota Wealth Management's iShares Biotechnology ETF position peaked at $2.54M in Q3 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.